Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program
Publication
, Conference
Kenchaiah, S; McMurray, JJ; Pocock, SJ; Wang, DL; Solomon, SD; McEntegart, M; Michelson, EL; Granger, CB; Pfeffer, MA
Published in: CIRCULATION
October 25, 2005
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 25, 2005
Volume
112
Issue
17
Start / End Page
U660 / U660
Location
Dallas, TX
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
78th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kenchaiah, S., McMurray, J. J., Pocock, S. J., Wang, D. L., Solomon, S. D., McEntegart, M., … Pfeffer, M. A. (2005). Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In CIRCULATION (Vol. 112, pp. U660–U660). Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS.
Kenchaiah, S., J. J. McMurray, S. J. Pocock, D. L. Wang, S. D. Solomon, M. McEntegart, E. L. Michelson, C. B. Granger, and M. A. Pfeffer. “Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” In CIRCULATION, 112:U660–U660. LIPPINCOTT WILLIAMS & WILKINS, 2005.
Kenchaiah S, McMurray JJ, Pocock SJ, Wang DL, Solomon SD, McEntegart M, et al. Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. U660–U660.
Kenchaiah, S., et al. “Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” CIRCULATION, vol. 112, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2005, pp. U660–U660.
Kenchaiah S, McMurray JJ, Pocock SJ, Wang DL, Solomon SD, McEntegart M, Michelson EL, Granger CB, Pfeffer MA. Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. U660–U660.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 25, 2005
Volume
112
Issue
17
Start / End Page
U660 / U660
Location
Dallas, TX
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
78th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology